With COVID-19 vaccine-makers pivoting production as the virus mutates, Jim Cafone, Pfizer’s senior vice president of global supply chain, said it is time for pharmaceutical companies to redevelop their logistic strategies, The Wall Street Journal repor…
Reauthorizing the FDA’s user fee program, which allows the agency to decide how much to charge pharmaceutical and medical device-maker companies for their product submissions, was added to a spending bill Sept. 22 to prevent a government shutdown…
The FDA is loosening requirements surrounding the distribution of naloxone to increase Americans’ access to the opioid overdose antidote.
From an unusual number of submissions of low-quality COVID-19 tests to limits at U.S. laboratories, the FDA faced multiple barriers in the early days of the COVID-19 pandemic, an HHS report found.
For many ASCs, including Wilmington (N.C.) Surgcare, staffing and supply chain issues have plagued operations since the beginning of the COVID-19 pandemic.
Drug and medical devicemakers with operations in Puerto Rico are cautiously optimistic that Hurricane Fiona will cause few ripples across the medical supply chain.
When health systems and public health departments were scrambling to respond to the COVID-19 pandemic in early 2020, New York bought ventilators and X-ray machines for more than a quarter of a billion dollars. The products were never used and are sitti…
Pharmacies and hospitals across the country are running out of Moderna’s tweaked vaccine booster, but the vaccine-maker said it expects supply to return to normal levels in a few days.
Houston-based Texas Medical Center on Sept. 20 unveiled plans to build a biomanufacturing center called the TMC BioPort. It will focus on manufacturing and distributing medical supplies, therapies and pharmaceuticals.
Here are nine supply chain updates for ASC leaders to know that Becker’s has reported since Sept. 14:
